Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
B. Sachdev,T. Takenaka,4 Authors,P. Elliott
2002 · DOI: 10.1161/01.CIR.0000012626.81324.38
Circulation · 562 Citations
TLDR
The prevalence of a potentially treatable cause of hypertrophy, Anderson-Fabry disease, in a HCM referral population is determined and its recognition is important given the advent of specific replacement enzyme therapy.